Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2000-05-18
2002-04-30
Fredman, Jeffrey (Department: 1655)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S024320, C536S024310, C536S024300, C536S024330
Reexamination Certificate
active
06379892
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to methods for determining the presence, absence or amount of
Chlamydia pneumoniae
producing organisms in specimens, including specimens from animals, humans and culture. The method involves using nucleic acid primers to amplify specifically a
Chlamydia pneumoniae
target, preferably using one of the techniques of Strand Displacement Amplification (SDA), thermophilic Strand Displacement Amplification (tSDA) or fluorescent real time tSDA.
BACKGROUND OF THE INVENTION
Chlamydia pneumoniae
is an intracellular microorganism which is difficult to isolate by culture. Evidence has accrued showing the relationship between heart disease and infection with
Chlamydia pneumoniae
. The worldwide burden from cardiovascular disease measured in disability adjusted life years (DALYs) is greater than either HIV or STDs.
Chlamydia pneumoniae
is responsible for about 20% of cases of community-acquired pneumonia (CAP). Nucleic acid amplification is a powerful technology, which allows rapid detection of specific target sequences. The oligonucleotide primers of the present invention are applicable to nucleic acid amplification and detection of
Chlamydia pneumoniae.
The following terms are defined herein as follows:
An amplification primer is a primer for amplification of a target sequence by extension of the primer after hybridization to the target sequence. Amplification primers are typically about 10-75 nucleotides in length, preferably about 15-50 nucleotides in length. The total length of an amplification primer for SDA is typically about 25-50 nucleotides. The 3′ end of an SDA amplification primer (the target binding sequence) hybridizes at the 3′ end of the target sequence. The target binding sequence is about 10-25 nucleotides in length and confers hybridization specificity on the amplification primer. The SDA amplification primer further comprises a recognition site for a restriction endonuclease 5′ to the target binding sequence. The recognition site is for a restriction endonuclease which will nick one strand of a DNA duplex when the recognition site is hemimodified, as described by G. Walker, et al. (1992.
Proc. Natl. Acad. Sci. USA
89:392-396 and 1992
Nucl. Acids Res.
20:1691-1696). Alternatively, to avoid using a hemimodified recognition site, a recognition site for a nicking enzyme may be used rather than the restriction endonuclease recognition site. The nucleotides 5′ to the restriction endonuclease recognition site (the “tail”) function as a polymerase repriming site when the remainder of the amplification primer is nicked and displaced during SDA. The repriming function of the tail nucleotides sustains the SDA reaction and allows synthesis of multiple amplicons from a single target molecule. The tail is typically about 10-25 nucleotides in length. Its length and sequence are generally not critical and can be routinely selected and modified. As the target binding sequence is the portion of a primer which determines its target-specificity, for amplification methods which do not require specialized sequences at the ends of the target the amplification primer generally consists essentially of only the target binding sequence. For example, amplification of a target sequence according to the invention using the Polymerase Chain Reaction (PCR) will employ amplification primers consisting of the target binding sequences of the amplification primers described herein. For amplification methods that require specialized sequences appended to the target other than the nickable restriction endonuclease recognition site and the tail of SDA (e.g., an RNA polymerase promoter for Self-Sustained Sequence Replication (3SR), Nucleic Acid Sequence-Based Amplification (NASBA) or the Transcription-Based Amplification System (TAS)), the required specialized sequence may be linked to the target binding sequence using routine methods for preparation of oligonucleotides without altering the hybridization specificity of the primer.
A bumper primer or external primer is a primer used to displace primer extension products in isothermal amplification reactions. The bumper primer anneals to a target sequence upstream of the amplification primer such that extension of the bumper primer displaces the downstream amplification primer and its extension product.
The terms target or target sequence refer to nucleic acid sequences to be amplified. These include the original nucleic acid sequence to be amplified, the complementary second strand of the original nucleic acid sequence to be amplified and either strand of a copy of the original sequence which is produced by the amplification reaction. These copies serve as amplifiable targets by virtue of the fact that they contain copies of the sequence to which the amplification primers hybridize.
Copies of the target sequence which are generated during the amplification reaction are referred to as amplification products, amplimers or amplicons.
The term extension product refers to the copy of a target sequence produced by hybridization of a primer and extension of the primer by polymerase using the target sequence as a template.
The term species-specific refers to detection, amplification or oligonucleotide hybridization to a species of organism or a group of related species without substantial detection, amplification or oligonucleotide hybridization to other species of the same genus or species of a different genus.
The term assay probe refers to any oligonucleotide used to facilitate detection or identification of a nucleic acid. Detector probes, detector primers, capture probes, signal primers and reporter probes as described below are examples of assay probes.
The term amplicon refers to the product of the amplification reaction generated through the extension of either or both of a pair of amplification primers. An amplicon may contain exponentially amplified nucleic acids if both primers utilized hybridize to a target sequence. Alternatively, amplicons may be generated by linear amplification if one of the primers utilized does not hybridize to the target sequence. Thus, this term is used generically herein and does not imply the presence of exponentially amplified nucleic acids.
SUMMARY OF THE INVENTION
The present invention provides oligonucleotide primers that can be used for amplification of a target sequence found in
Chlamydia pneumoniae
. More specifically, the target sequence comprises segments of the
Chlamydia pneumoniae
groES-EL gene. The amplification primers have been designed for high-efficiency, high-specificity amplification at elevated temperatures, such as in tSDA and the PCR, however, they are also useful in lower-temperature amplification reactions such as conventional SDA, 3SR or NASBA. Oligonucleotide assay probes that hybridize to the assay region of the amplified target are used to detect the amplification products.
The oligonucleotides of the invention may be used after culture as a means for confirming the identity of the cultured organism. Alternatively, they may be used with clinical samples from humans or animals, such as sputum, tissue and peripheral blood mononuclear cells, or with samples of contaminated food or water for detection and identification of
Chlamydia pneumoniae
nucleic acid using known amplification methods. In either case, the inventive oligonucleotides and assay methods provide a means for rapidly discriminating between
Chlamydia pneumoniae
and other microorganisms, allowing the practitioner to identify this microorganism rapidly without resorting to the more traditional procedures customarily relied upon. Such rapid identification of the specific etiological agent involved in an infection provides information that can be used to determine appropriate action within a short period of time.
REFERENCES:
patent: 5281518 (1994-01-01), Campbell et al.
patent: 5350673 (1994-09-01), Campbell et al.
patent: 5595874 (1997-01-01), Hogan et al.
Quinn, Thomas C.,Infectious Diseases11:301-307 (1998).
Campbell, Lee Ann et al.,J. of Clin. Mi
Becton Dickinson and Company
Einsmann Juliet
Fredman Jeffrey
Highet David W.
LandOfFree
Methods, kits and compositions of matter useful for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods, kits and compositions of matter useful for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, kits and compositions of matter useful for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2845575